ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,545Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 783

$645K Total Retail Price of All Prescriptions

Rank: 174 out of 783

690 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 13,621 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 682 629 1 4
SIMVASTATIN 643 592 2 3
OMEPRAZOLE 534 472 3 6
LEVOTHYROXINE SODIUM 529 515 4 1
HYDROCODONE-ACETAMINOPHEN 457 410 S3 5 2
AMLODIPINE BESYLATE 412 405 6 5
METFORMIN HCL 383 338 7 8
FUROSEMIDE 366 346 8 7
ATORVASTATIN CALCIUM 318 284 9 11
TRIAMTERENE-HCTZ 314 293 10 42
GLIMEPIRIDE 308 256 11 34
METOPROLOL TARTRATE 300 299 12 9
METOPROLOL SUCCINATE 262 253 13 13
WARFARIN SODIUM 240 240 14 10
PRAVASTATIN SODIUM 233 228 15 14
HYDROCHLOROTHIAZIDE 203 189 16 12
ATENOLOL 197 195 17 17
POTASSIUM CHLORIDE 194 183 18 16
LOSARTAN POTASSIUM 183 175 19 18
FLUTICASONE PROPIONATE 171 163 20 46
DIOVAN 166 151 21 49
TRAMADOL HCL 164 162 22 20
ALENDRONATE SODIUM 153 143 23 25
TAMSULOSIN HCL 136 121 24 26
ENALAPRIL MALEATE 135 135 25 68
FLUOXETINE HCL 128 121 26 45
DOXAZOSIN MESYLATE 124 124 27 87
GABAPENTIN 123 96 28 15
ALLOPURINOL 118 116 29 31
SPIRONOLACTONE 118 112 29 57
SERTRALINE HCL 111 102 31 22
LOVASTATIN 105 101 32 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 94 32 33
CARVEDILOL 104 92 34 21
SYNTHROID 102 102 35 47
CLOPIDOGREL 102 102 35 29
NIFEDIPINE ER 96 96 37 135
NEXIUM 92 68 38 28
DILTIAZEM 24HR ER 88 88 39 122
DIGOXIN 84 84 40 61
DONEPEZIL HCL 83 83 41 24
NITROFURANTOIN 81 81 42 225
ZOLPIDEM TARTRATE 79 72 43 23
TRAZODONE HCL 77 63 44 39
CRESTOR 75 74 45 27
VENLAFAXINE HCL ER 74 74 46 100
RANITIDINE HCL 74 73 46 44
PROAIR HFA 72 68 48 56
CIPROFLOXACIN HCL 68 65 49 62
LOSARTAN-HYDROCHLOROTHIAZIDE 66 65 50 53
PLAVIX 65 65 51 51
KLOR-CON M20 65 64 51 48
POLYETHYLENE GLYCOL 3350 62 61 53 43
BUPROPION HCL SR 60 60 54 166
EVISTA 60 60 54 92
CYMBALTA 60 59 54 35
PAROXETINE HCL 60 53 54 69
SPIRIVA 59 59 58 59
TERAZOSIN HCL 58 58 59 130
LIPITOR 58 53 59 114
ISOSORBIDE MONONITRATE ER 57 57 61 40
CITALOPRAM HBR 57 53 61 19
LANTUS SOLOSTAR 57 42 61 91
DIOVAN HCT 57 57 61 94
CLONIDINE HCL 53 53 65 60
PREDNISONE 53 52 65 36
NIFEDIAC CC 53 53 65 301
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.